348 results on '"Arsov C"'
Search Results
2. Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging
3. Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
4. MRI grading for the prediction of prostate cancer aggressiveness
5. Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
6. MRI-guided active surveillance without re-biopsy in patients with ISUP 1 and 2 prostate cancer – results of radical prostatectomy and mid-term follow up of the prospective PROMM-AS study
7. Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial
8. Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer
9. Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
10. Risikoadaptierte Früherkennung des Prostatakarzinoms – Update 2021
11. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
12. Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy
13. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy
14. PSA-Screening und molekulare Marker
15. PROMM-AS Studie: MRT-gestützte aktive Überwachung ohne jährliche Re-Biopsie bei Patienten mit ISUP-1- oder ISUP-2-Prostatakarzinom
16. Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
17. Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection
18. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate
19. Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
20. Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy
21. Risikovorhersage positiver Schnittränder bei radikaler Prostatektomie mittels präoperativer MRT
22. Selbstbild und erektile Dysfunktion 45-jähriger Männer: Ergebnisse eines Begleitprojekts der PROBASE-Studie
23. Risikoadaptiertes PSA-Screening und die PROBASE-Studie
24. Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
25. Complications of primary open or robotic RetroPeritoneal Lymph Node Dissection (RPLND) in stage II A/B patients with seminoma – results from the prospective phase II PRIMETEST trial
26. Effekt eines einmalig durchgeführten PSA-Screenings: Die CAP-Studie
27. MRI grading for the prediction of prostate cancer aggressiveness
28. Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate
29. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard
30. Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients
31. PSA-gestützte Früherkennung: Fluch oder Segen?
32. Standardisierung des multiparametrischen 3-T-MRT zur zielgerichteten Biopsie der Prostata
33. Der Stellenwert der Galvanotherapie beim lokal begrenzten Prostatakarzinom
34. Vergleich der diagnostischen Genauigkeit von PSMA PET/CT und der alleinigen CT-Komponente bei Patienten mit einem biochemischen Rezidiv eines Prostatakarzinoms
35. Präoperative Vorhersage des Prostatakarzinom-T-Stadiums mittels multiparametrischer MRT
36. MRT/US-Fusionsbiopsie der Prostata: Ursachen für falsch-negative gezielte Stanzen
37. MRT-Kontrollintervall von Patienten der PI-RADS-Kategorie 3
38. Granulomatöse Prostatitis als Erklärung für einen PI-RADS-5-Befund mit negativer Histologie
39. Kontrastmittel-freie Perfusionsbildgebung der Prostata: Prostatakarzinomdetektion mittels ASL
40. MR-Graduierung zur Einschätzung der Prostatakarzinomaggressivität
41. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
42. Wertigkeit der Durchführung von Spätaufnahmen in der 68Ga-PSMA-11 PET/CT bei Patienten mit biochemischem Rezidiv eines Prostata-Karzinoms
43. PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications
44. Equivocal pi-rads three lesions on prostate magnetic resonance imaging: Risk stratification strategies to avoid mri-targeted biopsies
45. Equivocal pi-rads three lesions on prostate magnetic resonance imaging: Risk stratification strategies to avoid mri-targeted biopsies
46. Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging
47. Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial
48. Risk stratification based on size of equivocal PI-RADS lesions may safely reduce the number of MRI-targeted biopsies
49. HP-4-5 Effect of Sexual Behavior on Prostate-Specific Antigen Levels in Middle-Aged Men Screened for Prostate Cancer: Results From the Probase Trial
50. Eine Risikostratifizierung von PI-RADS-3-Befunden durch die Läsionsgröße kann sicher die Anzahl an Prostatabiopsien reduzieren
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.